Stopping OAC After AF Ablation: No Cognitive Impairment
For years, the clinical dilemma for patients recovering from atrial fibrillation (AF) has been a high-stakes balancing act: continue lifelong oral anticoagulation (OAC) to prevent stroke and cognitive decline, or stop the medication to eliminate the risk of major bleeding. New data from the ALONE-AF trial substudy suggests that for a specific subset of patients, … Read more